ArticleVaccines2024

Phase I Clinical Study of the Subunit Betulin-Adjuvanted Tetravalent Candidate Influenza Vaccine TetraFluBet.

Igor Krasilnikov et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.